ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2011

MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib.

Jochen K Lennerz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.